Table 2.
Baseline value |
||||
---|---|---|---|---|
Event value | FVC>90% ↓ <90% |
FVC >90% ↓ <50% |
FVC 50-90% ↓ <50% |
|
N total | 64 | 64 | 166 | |
Time to event, years; median [95% CI] | 2.4 [1.1–3.1] | 4.9 [3.1 – NA] | 4.0 [2.8–5.4] | |
Event | FVC below event value, N (%) | 42 (66%) | 1 (1.6%) | 30 (18%) |
Dead, N (%) | 9 (14%) | 21 (33%) | 43 (26%) | |
Transplant, N (%) | 0 | 0 | 0 | |
Censoring | End of follow-up [FVC remained above event value], N (%) | 11 (17%) | 37 (58%) | 60 (36%) |
Antifibrotic treatment initiated, N (%) | 1 (1.6%) | 4 (6.3%) | 32 (19%) | |
Lost to follow-up, N (%) | 1 (1.6%) | 1 (1.6%) | 1 (0.6) |